News & Articles

Non-exclusive OEM license grants worldwide rights for Optimer binder in molecular biology applications

A comprehensive look at the mass spectrometry technologies powering faster workflows, smarter data, and more accessible analysis across industries

New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness

Phase 1 trial in aggressive brain cancer (glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platform

Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated

The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration

Gilboa-based formulations for wheat in Great Britain expected in 2027, followed by broader European launches in 2029

Scalable automation for low-viscosity samples

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media

Novel treatment offers non-immunosuppressive approach for localized acid neutralization and calcium delivery

Biopharma needs informatics platforms that are unified, flexible, and intelligent – ready not just for today’s science, but for what is coming next

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence

Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments

Explore the future of membrane protein therapeutics with innovative antibody platforms

Don Whitley Scientific reaches milestone showing unwavering commitment to microbiology

Innovative overhead stirring solution has been designed specifically for compatibility with Asynt DrySyn reaction vial inserts

Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use system

The American Board of Medical Specialties (ABMS) Portfolio Program will leverage Ovid Synthesis, which now features Wolters Kluwer’s Expert AI, to streamline the continuing certification credit process and fast-track patient improvement initiatives

Miniaturization and automated liquid handling transform NGS workflows for precious sample processing

Developed with leading pharmaceutical partners, SCE QC automates quality control workflows and sets a new standard for stats programming

Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea

The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape